| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insmed Inc (INSM) has 10 insiders with recent SEC Form 4 filings, including 5 buys and 7 sells. INSM is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 243.9K | $24.92M | - | |
| COO | 107.6K | $10.99M | - | |
| Other | 98.0K | $10.01M | - | |
| Other | 84.9K | $8.67M | - | |
| CEO | 81.4K | $8.31M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 9, 2019 | Hayden Donald J Jr | Director | Sale+OE | 6,286 | $32.99 | $207,375.14 | -9.2% | |
| Feb 26, 2019 | Altomari Alfred | Director | Sell | 5,500 | $30.00 | $165,000.00 | -17.5% | |
| Feb 22, 2019 | Hayden Donald J Jr | Director | Sale+OE | 14,900 | $28.08 | $418,392.00 | -19.3% | |
| Feb 15, 2019 | Hayden Donald J Jr | Director | Sale+OE | 100 | $27.90 | $2,790.00 | -0.2% | |
| Feb 15, 2019 | Altomari Alfred | Director | Sell | 5,500 | $27.50 | $151,250.00 | -14.9% | |
| Feb 5, 2019 | Altomari Alfred | Director | Sell | 5,500 | $25.00 | $137,500.00 | -13.0% | |
| Jan 10, 2019 | Altomari Alfred | Director | Sell | 5,500 | $22.50 | $123,750.00 | -11.5% | |
| Nov 12, 2018 | Sharoky Melvin Md74 | Director | Buy | 20,000 | $16.01 | $320,211.40 | +94.3% | |
| Nov 1, 2018 | Engelsen Steinar J | Director | Buy | 16,085 | $15.79 | $253,993.41 | +6.1% | |
| Nov 1, 2018 | Adsett Roger | Chief Commercial Officer | Buy | 3,000 | $15.97 | $47,907.00 | +19.2% |